Formulation development of antibodies using robotic system and High-Throughput Laboratory (HTL)

Journal of Pharmaceutical Sciences

Volumn 99, Issue 5, 2010, Pages 2279-2294

  Zhao, Hui ^a   Graf, Olivier ^a   Milovic, Nebojsa ^a   Luan, Xiaosong ^a   Bluemel, Markus ^a   Smolny, Markus ^a   Forrer, Kurt ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Analytical characterization; Analytical techniques; Antibody; Data management; High throughput laboratory; Liquid formulation development; Microplates; Robotic system; Stability study

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; SURFACTANT;

ANALYTIC METHOD; ARTICLE; AUTOMATION; CONTROLLED STUDY; DRUG FORMULATION; DRUG STABILITY; DYNAMIC LIGHT SCATTERING; GEL PERMEATION CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH THROUGHPUT LABORATORY; HIGH THROUGHPUT SCREENING; INFORMATION PROCESSING; ION EXCHANGE CHROMATOGRAPHY; LAB ON A CHIP; LABORATORY; LIGHT SCATTERING; LIQUID; POLYACRYLAMIDE GEL ELECTROPHORESIS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ROBOTICS; TURBIDITY; ULTRAVIOLET SPECTROSCOPY;

EID: 77951266838     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22008     Document Type: Article

References (41)

1. Bogart WC, Jr., Dean RT, Deo Y, Fuchs R, Mattis JA, McLean AA, Berger HJ. 1989. Practical considerations in the production, purification, and formulation of monoclonal antibodies for immunoscintigraphy and immunotherapy. Semin Nucl Med 19:202-220.
2. Chang BS, Hershenson S. 2002. Practical approaches to protein formulation development. In: Carpenter JF, Manning MC, editors. Rational design of stable protein formulations: Theory and practice. New York: Kluwer Academic/Plenum Publishers. pp. 1-25.
3. Cleland JL, Powell MF, Shire SJ. 1993. The development of stable protein formulations: A close look at protein aggregation, deamidation, and oxidation. Crit Rev Ther Drug Carrier Syst 10:307-377.
4. Shire SJ, Shahrokh Z, Liu J. 2004. Challenges in the development of high protein concentration formulations. J Pharm Sci 93:1390-1402. (Pubitemid 38725014)
5. Hermeling S, Crommelin DJA, Schellekens H, Jiskoot W. 2004. Structure-immunogenicity relationship of therapeutic proteins. Pharm Res 21:897-903.
6. Braun A, Kwee L, Labow MA, Alsenz J. 1997. Protein aggregates seem to play a key role among the parameters influencing the antigenicity of interferon alpha (IFN-alpha) in normal and transgenic mice. Pharm Res 14:1472-1478. (Pubitemid 27481082)
7. Volkin DB, Middaugh CR. 1996. The characterization, stabilization, and formulation of acidic fibroblast growth factor. Pharm Biotechnol 9:181-217.
8. Baynes BM, Trout BL. 2004. Rational design of solution additives for the prevention of protein aggregation. Biophys J 87:1631-1639.
9. Harris RJ. 2005. Heterogeneity of recombinant antibodies: Linking structure to function. Dev Biol (Basel) 122:117-127. (Pubitemid 43002214)
10. Page M, Ling C, Dilger P, Bentley M, Forsey T, Longstaff C, Thorpe R. 1995. Fragmentation of therapeutic human immunoglobulin prearations. Vox Sang 69:183-194.
11. Kroon DJ, Baldwin-Ferro A, Lalan P. 1992. Identification of sites of degradation in a therapeutic monoclonal antibody by peptide mapping. Pharm Res 9:1386-1393.
12. Lam XM, Yang JY, Cleland JL. 1997. Antioxidants for prevention of methionine oxidation in recombinant monoclonal antibody HER2. J Pharm Sci 86:1250-1255.
13. Griffiths HR. 2000. Antioxidants and protein oxidation. Free Radic Res 33:S47-S58.
14. Hasegawa G, Kikuchi M, Kobayashi Y, Saito Y. 2005. Synthesis and characterization of a novel reagent containing dansyl group, which specifically alkylates sulfhydryl group: An example of application for protein chemistry. J Biochem Biophys Methods 63:33-42. (Pubitemid 40693934)
15. Carpenter JF, editor. 1995. Deamidation and isoaspartate formation in peptides and proteins. Boca Raton: CRC Press.
16. Manning MC, Patel K, Borchardt RT. 1989. Stability of protein pharmaceuticals. Pharm Res 6:903-918.
17. Robinson AB, McKerrow JH, Cary P. 1970. Controlled deamidation of peptides and proteins: An experimental hazard and a possible biological timer. Proc Natl Acad Sci USA 66:753-757.
18. Mimura Y, Kabat EA, Tanaka T, Fujimoto M, Takeo K, Nakamura K. 1995. Microheterogeneity of mouse antidextran monoclonal antibodies. Electrophoresis 16:116-123.
19. Zhang W, Czupryn MJ. 2003. Analysis of isoaspartate in a recombinant monoclonal and its charge isoforms. J Pharm Biomed Anal 30:1479-1490. (Pubitemid 35435340)
20. Cleland JL, Powell MF, Shire SJ. 1993. The development of stable protein formulations: A close look at protein aggregation, deamidation, and oxidation. Crit Rev Ther Drug Carrier Syst 10:307-377.
21. Xie M, Schowen RL. 1999. Secondary structure and protein deamidation. J Pharm Sci 88:8-13.
22. Harris RJ, Kabakoff B, Macchi FD, Shen FJ, Kwong M, Andya JD, Shira SJ, Bjork N, Totpal K, Chen AB. 2001. Identification of multiple sources of charge heterogeneity in a recombinant antibody. J Chromatogr B Biomed Sci Appl 752:233-245. (Pubitemid 32168159)
23. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, Smith HO, Yandell M, Evans CA, Holt RA, Gocayne JD, Amanatides P, Ballew RM, Huson DH, Wortman JR, Zhang Q, Kodira CD, Zheng XH, Chen L, Skupski M, Subramanian G, Thomas PD, Zhang J, Gabor Miklos GL, Nelson C, Broder S, Clark AG, Nadeau J, McKusick VA, Zinder N, Levine AJ, Roberts RJ, Simon M, Slayman C, Hunkapiller M, Bolanos R, Delcher A, Dew I, Fasulo D, Flanigan M, Florea L, Halpern A, Hannenhalli S, Kravitz S, Levy S, Mobarry C, Reinert K, Remington K, Abu-Threideh J, Beasley E, Biddick K, Bonazzi V, Brandon R, Cargill M, Chandramouliswaran I, Charlab R, Chaturvedi K, Deng Z, Francesco VD, Dunn P, Eilbeck K, Evangelista C, Gabrielian AE, Gan W, Ge W, Gong F, Gu Z, Guan P, Heiman TJ, Higgins ME, Ji R-R, Ke Z, Ketchum KA, Lai Z, Lei Y, Li Z, Li J, Liang Y, Lin X, Lu F, Merkulov GV, Milshina N, Moore HM, Naik AK, Narayan VA, Neelam B, Nusskern D, Rusch DB, Salzberg S, Shao W, Shue B, Sun J, Wang ZY, Wang A, Wang X, Wang J, Wei M-H, Wides R, Xiao C, Yan C, Yao A, Ye J, Zhan M, Zhang W, Zhang H, Zhao Q, Zheng L, Zhong F, Zhong W, Zhu SC, Zhao S, Gilbert D, Baumhueter S, Spier G, Carter C, Cravchik A, Woodage T, Ali F, An H, Awe A, Baldwin D, Baden H, Barnstead M, Barrow I, Beeson K, Busam D, Carver A, Center A, Cheng ML, Curry L, Danaher S, Davenport L, Desilets R, Dietz S, Dodson K, Doup L, Ferriera S, Garg N, Gluecksmann A, Hart B, Haynes J, Haynes C, Heiner C, Hladun S, Hostin D, Houck J, Howland T, Ibegwam C, Johnson J, Kalush F, Kline L, Koduru S, Love A, Mann F, May D, McCawley S, McIntosh T, McMullen I, Moy M, Moy L, Murphy B, Nelson K, Pfannkoch C, Pratts E, Puri V, Qureshi H, Reardon M, Rodriguez R, Rogers Y-H, Romblad D, Ruhfel B, Scott R, Sitter C, Smallwood M, Stewart E, Strong R, Suh E, Thomas R, Tint NN, Tse S, Vech C, Wang G, Wetter J, Williams M, Windsor S, Winn-Deen E, Wolfe K, Zaveri J, Zaveri K, Abril JF, Guigó R, Campbell MJ, Sjolander KV, Karlak B, Kejariwal A, Mi H, Lazareva B, Hatton T, Narechania A, Diemer K, Muruganujan A, Guo N, Sato S, Bafna V, Istrail S, Lippert R, Schwartz R, Walenz B, Yooseph S, Allen D, Basu A, Baxendale J, Blick L, Caminha M, Carnes-Stine J, Caulk P, Chiang YH, Coyne M, Dahlke C, Mays AD, Dombroski M, Donnelly M, Ely D, Esparham S, Fosler C, Gire H, Glanowski S, Glasser K, Glodek A, Gorokhov M, Graham K, Gropman B, Harris M, Heil J, Henderson S, Hoover J, Jennings D, Jordan C, Jordan J, Kasha J, Kagan L, Kraft C, Levitsky A, Lewis M, Liu X, Lopez J, Ma D, Majoros W, McDaniel J, Murphy S, Newman M, Nguyen T, Nguyen N, Nodell M, Pan S, Peck J, Peterson M, Rowe W, Sanders R, Scott J, Simpson M, Smith T, Sprague A, Stockwell T, Turner R, Venter E, Wang M, Wen M, Wu D, Wu M, Xia A, Zandieh A, Zhu X. 2001. The sequence of the human genome. Science 291:1304-1351.
24. Kreusch S, Schwedler S, Tautkus B, Cumme GA, Horn A. 2003. UV measurements in microplates suitable for high-throughput protein determination. Anal Biochem 313:208-215. (Pubitemid 36259944)
25. Chapman E, Wong CH. 2002. A pH sensitive colorimetric assay for the high-throughput screening of enzyme inhibitors and substrates: A case study using kinases. Bioorg Med Chem 10:551-555. (Pubitemid 34112446)
26. Wong SK, Lu Y, Heineman W, Palmer J, Courtney C. 2005. Fully automated solid weighing workstation. J Biomol Screen 10:524-531. (Pubitemid 41233231)
27. Sundberg SA. 2000. High-throughput and ultra-high-throughput screening: Solution- and cell based approaches. Curr Opin Biotechnol 11:47-53.
28. Bevan CD, Lloyd RS. 2000. A high-throughput screening method for the determination of aqueous drug solubility using laser nephelometry in microtiter plates. Anal Chem 72:1781-1787.
29. Plotnikov V, Rochalski A, Brandts M, Brandts JF, Williston S, Erasea V, Lin L. 2002. An autosampling differential scanning calorimeter instrument for studying molecular interactions. Assay Drug Dev Technol 1:83-89.
30. Hui R, Edwards A. 2003. High-throughput protein crystallization. J Struct Biol 142:154-161.
31. Chan KL, Kazarian SG. 2005. Fourier transform infrared imaging for high-throughput analysis of pharmaceutical formulations. J Comb Chem 7:185-189. (Pubitemid 40522000)
32. Tielmann P, Boese M, Luft M, Reetz MT. 2003. A practical high-throughput screening system for enantioselectivity by using FTIR spectroscopy. Chemistry 9:3882-3887.
33. He Y, Yeung ES. 2003. High-throughput screening of kinase inhibitors by multiplex capillary electrophoresis with UV absorption detection. Electrophoresis 24:101-108. (Pubitemid 36175857)
34. Capelle MAH, Gurny R, Arvinte T. 2007. High throughput screening of protein formulation stability: Practical considerations. Eur J Pharm Biopharm 65:131-148. (Pubitemid 46038086)
35. Pellaud J, Schote U, Arvinte T, Seelig J. 1999. Conformation and self-association of human recombinant transforming growth factor-beta3 in aqueous solutions. J Biol Chem 274:7699-7704. (Pubitemid 129518156)
36. Chan KLA, Kazarian SG. 2005. Fourier transform infrared imaging for high-throughput analysis of pharmaceutical formulations. J Comb Chem 7:185-189. (Pubitemid 40522000)
37. Li N, Kessler K, Bass L, Zeng D. 2007. Evaluation of the iCE280 Analyzer as a potential high-throughput tool for formulation development. J Pharm Biomed Anal 43:963-972. (Pubitemid 46185806)
38. Capelle M, Gurny R, Arvinte T. 2009. A high throughput protein formulation platform. Case study of Salmon calcitonin. Pharmaceutical Research 26:118-128.
39. Eckhardt BM, Oeswein JQ, Yeung DA, Milby TD, Bewley TA. 1994. A turbidimetric method to determine visual appearance of protein solutions. J Pharm Sci Technol 48:64-70.
40. Kueltzo LA, Ersoy B, Ralston JP, Middaugh CR. 2003. Derivative absorbance spectroscopy and protein phase diagrams as tools for comprehensive protein characterization: A bGCSF case study. J Pharm Sci 92:1805-1820. (Pubitemid 37071814)
41. Nayar R, Manning MC. 2002. High throughput formulation: Strategies for rapid development of stable protein products. In: Carpenter JF, Manning MC, editors. Rational design of stable protein formulations: Theory and practice. New York: Kluwer Academic/Plenum Publishers. pp. 177-198.